Is Xylem Inc (XYL) Stock Over or Undervalued?

Xylem Inc (XYL) receives a weak valuation score of 35 from InvestorsObserver analysis. Our proprietary scoring system considers the overall health of the company by looking at the stock's price, earnings, and growth rate to determine if it represents a good value. XYL holds a better value than 35% of stocks at its current price. Investors who are focused on long-term growth through buy-and-hold investing will find the Valuation Rank especially relevant when allocating their assets.

XYL gets a 35 Valuation Rank today. Find out what this means to you and get the rest of the rankings on XYL!

See Full XYL Report

Metrics Analysis

XYL has a trailing twelve month Price to Earnings (PE) ratio of 50.7. The historical average of roughly 15 shows a poor value for XYL stock as investors are paying higher share prices relative to the company's earnings. XYL's high trailing PE ratio shows that the firm has been trading above its fair market value recently. Its trailing 12-month earnings per share (EPS) of 0.55 does not justify the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings. XYL has a 12 month forward PE to Growth (PEG) ratio of 2.64. Markets are overvaluing XYL in relation to its projected growth as its PEG ratio is currently above the fair market value of 1. 0.55's PEG comes from its forward price to earnings ratio being divided by its growth rate. PEG ratios are one of the most used valuation metrics due to its incorporation of more company fundamentals metrics and a focus on the firm's future rather than its past.

Summary

XYL's valuation metrics are weak at its current price due to a overvalued PEG ratio despite strong growth. XYL's PE and PEG are worse than the market average resulting in a below average valuation score. Click Here to get the full Report on Xylem Inc (XYL) stock.